Results 21 to 30 of about 5,573 (260)

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice [PDF]

Ophthalmology and Therapy
Introduction Anti-vascular endothelial growth factor (VEGF) is generally given using pro re nata or “treat-and-extend” (T&E) regimens for neovascular age-related macular degeneration (nAMD).
Eloi Debourdeau, Helene Beylerian, Vuong Nguyen, Daniel Barthelmes, Mark Gillies, Pierre Henry Gabrielle, Stela Vujosevic, Louise Otoole, Martin Puzo, Catherine Creuzot-Garcher, Benjamin Wolff, Vincent Daien, The Fight Retinal Blindness! Study Group   +12 more
doaj   +2 more sources

Pro Re Nata Use of Psychotropic Medications in Assisted Living [PDF]

Innov Aging, 2020
Abstract This study examined the use of pro re nata (PRN, or as needed) psychotropic medications among assisted living (AL) residents. We examined prescriptions and administrations, and compared use based on dementia diagnosis. Data sources included interviews with administrators of 250 AL communities in 7 states and medication ...
Carder P, Zimmerman S, Wretman C, Dys S, Sloane P.   +4 more
europepmc   +3 more sources

One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study [PDF]

Ophthalmology and Therapy
Introduction The aim of this study was to compare the efficacy of the treat-and-extend (TAE) regimen versus the pro re nata (PRN) regimen in patients with bevacizumab-resistant diabetic macular edema (DME) treated with aflibercept, with or without ...
Zubeyir Yozgat, Mehmed Ugur Isik, Mehmet Cem Sabaner   +2 more
doaj   +2 more sources

Pro Re Nata Prescription and Perception Difference between Doctors and Nurses. [PDF]

Korean J Fam Med, 2014
Pro re nata (PRN) prescription is a frequently used prescription method in hospitals. This study was conducted to investigate actual condition of PRN prescription and whether administration error occurred because of perception difference between doctors and nurses.From May to July 2012, a survey was conducted among 746 doctors and nurses (88 doctors ...
Oh SH, Woo JE, Lee DW, Choi WC, Yoon JL, Kim MY.   +5 more
europepmc   +4 more sources

Administration of pro re nata medications by the nurse to incapacitated patients: An ethical perspective [PDF]

Clinical Ethics, 2021
The administration of pro re nata medications is the responsibility of the nurse. However, ethical uncertainties often happen due to the inability of incapacitated patients to collaborate with the nurse in the process of decision making for pro re nata medication administration.
Mojtaba Vaismoradi, Cathrine Fredriksen Moe, María Flores Vizcaya-Moreno, Piret Paal   +3 more
openalex   +5 more sources

Comparing the effectiveness of treating branch retinal vein occlusion with a novel one and stepped pro re nata treatment protocol. [PDF]

Medicine (Baltimore)
Chen PJ, Hsu AY, Lai CT, Lin CJ, Hsia NY, Chen WL, Tien PT, Lin JM, Chen SN, Tsai YY.   +9 more
europepmc   +4 more sources

Pro re nata medications in mental health: Results of a transversal study

L'Encéphale, 2022
Pro re nata are frequent in psychiatry. The risks engendered by this treatment requires that their prescription and administration be made safer. The frequency of administration of pro re nata depends mainly on the nurse's clinical judgment.Our first objective was to assess nurses' satisfaction about the quality of doctors' pro re nata prescriptions ...
Guillaume Legrand, E. Gregoire, D. Fererol, Z. Cardinaud, C. Cussac-Buchdahl, A. Debost-Legrand   +5 more
  +7 more sources

Management of Polypoidal choroidal vasculopathy and diabetic retinopathy: Practice patterns amongst vitreoretinal surgeons of India—A VRSI survey [PDF]

Indian Journal of Ophthalmology
Purpose: To present results from the Vitreo Retina Society–India (VRSI) 2024 Preference and Trends Survey, focusing on polypoidal choroidal vasculopathy (PCV) and diabetic retinopathy (DR) management practices among Indian vitreoretinal surgeons. Methods:
Manavi D Sindal, Priyanka Mahendrakar, Akshat Kothari, Mudit Tyagi, Divyansh Mishra, Shivraj Tagare, Mihir Vaidya, Mahesh Shanmugam   +7 more
doaj   +2 more sources

One-Year Outcomes of 1 Dose versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial [PDF]

Journal of Ophthalmology, 2019
Purpose. To compare the functional and anatomical outcomes of one dose and three loading doses followed by the pro re nata (PRN) regimen in Chinese neovascular age-related macular degeneration (nvAMD) (including polypoidal choroidal vasculopathy (PCV ...
Fenghua Wang, Yuanzhi Yuan, Ling Wang, Xiaofeng Ye, Jingke Zhao, Mengxi Shen, Qi Zhang, Ding Xu, Guoyou Qin, Wei Zhang, Fei Yuan, Qing Chang, Peiquan Zhao, Fang Wang, Xiaodong Sun   +14 more
doaj   +2 more sources

Use of electronic health record data to examine administrations of pro re nata analgesics during hip fracture post-acute care. [PDF]

Pharmacoepidemiol Drug Saf
Riester MR, Zhang Y, Hayes KN, Beaudoin FL, Zullo AR.   +4 more
europepmc   +3 more sources